X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

[Audio] AF COVID-19 PODCAST: Can Construction Projects Move Forward?

Stay at home orders. Social distancing measures. We talked with Mark Bloom and Andrew Ross about the...

Read More >

The 5 Biggest Employment Law Developments of 2019

What were the five biggest employment law developments in 2019? From new laws to big decisions, we t...

Read More >

M&A Watch: Seeking Your True Purpose? Delaware Offers Guidance on Section 220 Requests

Following Corwin v. KKR Financial Holdings and other Delaware cases that have reinforced the standar...

Read More >

Pay-if-Paid Clauses: A Surety’s Defense for Payment Bond Claims?

A construction project can be a breeding ground for general contractor versus subcontractor payment ...

Read More >

COVID-19 Update: Practical Guide for Employers in Singapore

The coronavirus outbreak which was first alerted to the World Health Organisation (WHO) by Chinese a...

Read More >

Our Perspective: SEC Should Truly Take "No Action" on Rule 14a-8 Shareholder Proposal Requests

The Background: The U.S. Securities and Exchange Commission ("the SEC") has announced that it may no...

Read More >